Aldeyra Therapeutics Disclosed Clinical Development Plan For Resubmission Of New Drug Application For Reproxalap In Dry Eye Disease
Aldeyra Therapeutics公布了重新提交治疗干眼病的瑞普沙拉普新药申请的临床开发计划
Aldeyra Therapeutics Disclosed Clinical Development Plan For Resubmission Of New Drug Application For Reproxalap In Dry Eye Disease
Aldeyra Therapeutics公布了重新提交治疗干眼病的瑞普沙拉普新药申请的临床开发计划
使用浏览器的分享功能,分享给你的好友吧